Risk Assessment in Pulmonary Arterial Hypertension Patients: The Long and Short of it

Authors: Raymond L. Benza MD, Lisa Carey Lohmueller, Jidapa Kraisangka, Manreet Kanwar MD Pulmonary arterial hypertension (PAH) is a chronic and rapidly progressive disease that is characterized by extensive narrowing of the pulmonary vasculature, leading to increases in pulmonary vascular resistance, subsequent right ventricular dysfunction, and eventual death. There are currently multiple approved drugs—developed as single or combination […]